New Orleans, La.--The most recent report compiled by the United StatesPharmacopeia (USP) found that high-alert medications have continued to harmhospitalized patients, according to Diane D. Cousins (pictured at left),RPh, vice president of USP's Center for the Advancement of Patient Safety.Cousins announced the results of the MEDMARX report, based on data from2002, at a press conference at the 38th ASHP Midyear Clinical Meeting.
Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.
People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.
Bronchiectasis affected 221.6 per 100,000 people in the U.S. over five years, which is higher than earlier national estimates, according to a study published in CHEST.
Adding Sunharbo (asundexian), a first-in-class factor XI inhibitor, to single or dual antiplatelet therapy reduces ischemic stroke risk without increasing the risk of major bleeding.